最新上傳 | 台灣泌尿科醫學會E-School

#0029 Current Australian management trend of male stress incontinence of the 21st century

04-23

#0027 Temporal trends in the management of urethral stricture disease in Australia over the 21st century

04-23

#1109 Prevalence of prostate cancer among men undergoing TRUS guided prostatic biopsies, with correlation of serum PSA levels and distribution of Gleason grade groups: A single tertiary care centre experience.

04-23

#1098 Hereditary Prostate Cancer: A Case Report of a Cancer Pedigree

04-23

#1096 High-Grade Undifferentiated Prostate Malignancy in a Young Aboriginal Male: A Case Report

04-23

#0834 The Role of 18F PSMA-1007 PET/CT in the Staging and Detection of Recurrence of Prostate Cancer. A Scoping Review.

04-23

#0816 A comparison between the Australian Cancer Council optimal care pathway for men with prostate cancer and the actual care in a public tertiary centre in Australia

04-23

#0776 Accuracy of Targeted Transrectal Ultrasound Prostate Biopsies

04-23

#0711 Discovery and Validation of Nitroolefin-Based Covalent GPX4 Inhibitors for Inducing Ferroptosis in Prostate Cancer

04-23

#0704 Enhancer transcription profiling reveals an enhancer RNA-driven ferroptosis and new therapeutic opportunities in prostate cancer

04-23

#0684 Outcomes of Treatment for Localized Prostate Cancer in a Single Institution: Comparison of Radical Prostatectomy and Radiation Therapy Using Inverse Probability of Treatment Weighting (IPTW) Analysis

04-23

#0676 Reevaluating Role of Vitamin D in Prostate Cancer Pathology: The Impact of MRI-Guided Staging

04-23

#0668 Intraductal Carcinoma in Localised Prostate Cancer is Over-Represented in Patients with No Intraprostatic Uptake Pattern on PSMA PET

04-23

#0666 Genitourinary toxicity following radiation therapy is not just about haematuria- lessons from 7 years of a specialist radiation cystitis clinic.

04-23

#0579 Circulating microRNA profiling for prediction of oncological outcomes in prostate cancer patients following radical prostatectomy

04-23

#0109 A research of burden and risk factors of prostate diseases from 1990 to 2021 in 21 regions and 204 territories

04-23

#0062 Combining percentage prostate-specific antigen reduction and multiparametric magnetic resonance imaging to reduce unnecessary biopsy after focal therapy with high-intensity focused ultrasound for prostate cancer

04-23

#1108 A 10-year single center experience review of partial cystectomy from 2014 to 2024

04-23

#1105 Primary Malignant Melanoma of the Bladder Initially Diagnosed as Urothelial Carcinoma: A Case Report

04-23

#1016 The Potential of Preoperative LIPI as a Survival Predictor in Bladder Cancer Patients

04-23

#1006 IL-22/IL22R1 promotes the progression of bladder transitional cell carcinoma by downregulating EGR1, which is achieved by YBX1 binding to its mRNA

04-23

#0991 Clinical experience of the orthotopic W-pouch neobladder for urinary diversion post-radical cystectomy in Indonesia: a multicenter study

04-23

#0963 Oncological outcomes of partial cystectomy versus radical cystectomy in patients with T2N0M0 bladder cancer: A retrospective study based on the SEER database

04-23

#0958 HDACs inhibitor sensitizes the efficacy of cisplatin via H3K18la mediated transcriptional upregulation of DHRS2 in bladder cancer

04-23

/ 155